
325: Biden's health care AI czar, a new obesity company, and its dealmaking CEO
The Readout Loud
00:00
Progress and Challenges in Drug Development
This chapter examines a company's journey in drug development, highlighting a lead molecule set for phase three trials and the competitive landscape. It also explores the leadership's ambitions that go beyond just leisure, indicating a strong commitment to market advancement.
Transcript
Play full episode